Cultrera di Montesano, Sebastiano https://orcid.org/0000-0001-6249-0832
D’Ascenzo, Davide https://orcid.org/0000-0002-0607-8488
Raghavan, Srivatsan
Amini, Ava P. https://orcid.org/0000-0002-8601-6040
Winter, Peter S. https://orcid.org/0000-0002-6557-3219
Crawford, Lorin https://orcid.org/0000-0003-0178-8242
Article History
Received: 28 May 2025
Accepted: 12 December 2025
First Online: 30 January 2026
Change Date: 6 February 2026
Change Type: Update
Change Details: In the version of this article initially published, refs. <sup>23</sup> (
Change Details: https://doi.org/10.5281/zenodo.17211022
Change Details: ) and <sup>24</sup> (
Change Details: https://doi.org/10.5281/zenodo.17554556
Change Details: ) were not listed correctly with doi format, as is now amended in the HTML and PDF versions of the article.
Competing interests
: S.R. holds equity in Amgen. S.R. and P.S.W. receive research funding from Microsoft. A.P.A. and L.C. are employees of Microsoft and own equity in Microsoft. S.C.d.M. reports compensation from Engine Ventures and Mobius Biotechnology GmbH for consulting/speaking unrelated to this work. P.S.W. reports compensation from Engine Ventures and AbbVie for consulting/speaking unrelated to this work. The other authors have no competing interests.